Update on Autoimmune Pancreatitis and IgG4‐Related Disease
United European Gastroenterology Journal · 2025-02 · 13 (1) · 107-115
DOI: 10.1002/ueg2.12738 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift United European Gastroenterology Journal, online erschienen am 21.12.2024. Verfasst von Marco Lanzillotta und 3 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Immunoglobulin G4-Related Disease, Immunoglobulin G, Autoimmune Diseases. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Autoimmune pancreatitis is an increasingly recognized inflammatory type of subacute pancreatitis; two subtypes of autoimmune pancreatitis have been identified so far: the “lymphoplasmacytic” type 1 variant and the “neutrophilic” type 2 variant. Type 1 autoimmune pancreatitis represents the most common manifestation of IgG4‐related disease, a fibro‐inflammatory disorder characterized by elevated IgG4 levels in the serum and affected tissues. Type 2 autoimmune pancreatitis is a pancreas‐specific disorder that frequently occurs in the context of inflammatory bowel diseases. Due to the complexity of both diseases, a comprehensive work up with imaging, laboratory, and histological studies is required to achieve a diagnosis and rule out malignancies. Glucocorticoids represent the cornerstone of the treatment, often supported by other immunosuppressive drugs in case of steroid intolerance or aggressive disease. Maintenance treatment is often employed in type 1 autoimmune pancreatitis because of the higher relapse rate compared with type 2 autoimmune pancreatitis. In this review, we summarize the key concept of autoimmune pancreatitis, delve into the differential diagnosis between the two subtypes, and cover the recent relevant research findings and pressing unmet needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy.
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UNIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Department of Upper Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Clinical Science, Intervention, and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Marco Lanzillotta, Miroslav Vujasinovic, Johannes-Matthias Löhr, Emanuel Della Torre
Zitieren
APA
Lanzillotta, M., Vujasinovic, M., Löhr, J. M., & Della Torre, E. (2025). Update on Autoimmune Pancreatitis and IgG4‐Related Disease. United European Gastroenterology Journal, 13(1), 107-115. https://doi.org/10.1002/ueg2.12738
Vancouver
Lanzillotta M, Vujasinovic M, Löhr JM, Della Torre E. Update on Autoimmune Pancreatitis and IgG4‐Related Disease. United European Gastroenterology Journal. 2025;13(1):107-115. doi:10.1002/ueg2.12738
BibTeX
@article{Lanzillotta2025,
author = {Lanzillotta, Marco and Vujasinovic, Miroslav and Löhr, Johannes-Matthias and Della Torre, Emanuel},
title = {Update on Autoimmune Pancreatitis and IgG4‐Related Disease},
journal = {United European Gastroenterology Journal},
year = {2025},
volume = {13},
number = {1},
pages = {107--115},
doi = {10.1002/ueg2.12738}
}
EUVIMED